董春燕 主任医师，副教授
硕士招生类型：学术型；专业型
硕士招生专业：肿瘤学；全科医学
博士招生类型：学术型；专业型
博士招生专业：肿瘤学
所在院系：附属东方医院
联系方式：**@163.com
课题组链接：
研究方向
主要任职
科研业绩

乳腺癌转移机制、乳腺癌肿瘤干细胞转化研究及纳米抗肿瘤药物治疗研究；Metastasis mechanism study of breast cancer，breast cancer stem cell clinical translational research，target drug delivery system study for breast cancer treatment
乳腺肿瘤内科主任Director of department of Breast Medical Oncology
国家基金委评审专家National Research Foundation Assessment Expert
上海市科委评审专家 Shanghai Scientific Committee Assessment Expert
上海市浦东新区肿瘤防治委员会委员Member of Pudong New District Cancer prevention and control committee
东上海肿瘤疑难病例会诊中心专家Specialist of tumor difficult cases consultation center in the east of Shanghai
中国医药生物技术协会精准医疗分会委员Committee member of Precision medical chapter of China Medicinal Biotechnology Association
组建与同济大学纳米生命科学院合作的肿瘤纳米靶向药物研究合作课题组。致力于纳米抗肿瘤研究，乳腺癌转移复发分子机制研究以及肿瘤干细胞临床转化研究。承担国家自然基金、上海市科委以及浦东新区科委课题多项，已经完成结题国家教委基金、上海市科委、同济大学等多项课题,累积科研经费360余万。第一作者通讯作者发表SCI论文18篇。组建了乳腺肿瘤多学科诊治团队，专注于乳腺癌早期诊断和治疗、术后辅助治疗、复发转移的诊断和规范治疗，开展化疗、放疗、内分泌治疗、靶向治疗、免疫治疗、微创介入治疗、热疗、乳腺癌患者的全程管理。科室的特点是“转移性乳腺癌的优化全程管理与个体化精准治疗”。承担了多项临床研究以及转化研究课题。
Dr. Dong have formed Targeted Anti-Tumor Nanodrug Research Group with the Institute for Biomedical Engineering & Nano Science of Tongji university. Dedicated to improve anti-tumor drug efficacy, relevant metastasis mechanism research and breast cancer stem cell clinical translational research.
Undertook a number of National Natural Science Foundation, Shanghai Committee of Science and Technology, Pudong New District Committee of Science and Technology research projects. Accumulated more than 3.6 million research funds. Published over 18 research papers in SCI journals as the first author and corresponding author.